SweetValueLab
Write for us

Cencora, Inc. — Intrinsic Value & Fair Price

COR
NYSEHealthcareMedical - DistributionCIK 0001140859cencora.comAbout COR
Valuation grade ?A
Quant grade ?S
Last close · Oct 30, 2026330.84+0.31 (+0.09%)
Model value · DCF · Perpetuity growth · 5y
402.39
Cencora closed at $330.84 — undervalued by 18% vs model.
320.40the model's range534.72

DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.

Other models
76.68 – 491.86
Wall St. target
362.50 9% below
Below model, 1y
17 of 30 days

How it is valued

Valued asMature & stable
Moderate growth (~11% recent)Thin margins (0.5% net margin)Highly cyclical earningsHigh leverage (D/E 7.1x)Strong FCF yield (5.1%)
What growth the price implies: the reverse DCF

Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.